The Epigenetics and Nanomedicine research group was established in 2015 as a result of the CINN’s growing activity in the biomedical field.

The current research lines are focused on eight main areas:

• Application of new technologies in the search for epigenetic biomarkers related to aging and human carcinogenesis that are useful in clinical practice
• Development of nanoparticles for the administration of combination of antitumor epigenetic drugs
• Identification of epigenetic changes in response to nanomaterials, particularly graphene and graphenic materials
• In-situ analysis of subcellular architecture
• New inorganic antimicrobial products
• Omics in health: Advanced techniques to study the bioactive role of food
• Tissue engineering: Solutions against peri-implantitis, ceramic materials for long-lasting implants, bone substitutes
• Identification and pharmacological manipulation of the molecular mechanisms involved in the signaling of Bone Morphogenetic Proteins (BMPs)
• Computational biochemistry of membrane receptors 

Our researchers lead 5 research groups of the Health Research Institute of the Principality of Asturias  (ISPA):

• Subcellular architecture. Dr. José Jesús Fernández
• Cancer Epigenetics and Nanomedicine. Prof. Mario Fernández Fraga
• Nanomaterials and Tissue Engineering. Dr. Adolfo Fernández Valdes
• Proteomics Unit. Dr. Ignacio Ortea
• Tissues-specific BMPs signalling. Dr. Gonzalo Sánchez Duffhues